Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205
HOEHLER, T, VON WICHERT, G, HALLEK, M, HOFHEINZ, R, HACKER, U. T, SCHIMANSKI, C, KANZLER, S, MOEHLER, M. H, HINKE, A, SEUFFERLEIN, T, SIEBLER, J, HOCHHAUS, A, ARNOLD, D
Published in British journal of cancer (17.09.2013)
Published in British journal of cancer (17.09.2013)
Get full text
Journal Article
Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Bang, Y.-J, Ruiz, E.Yañez, Van Cutsem, E., Lee, K.-W, Wyrwicz, L., Schenker, M., Alsina, M., Ryu, M.-H, Chung, H.-C, Evesque, L., Al-Batran, S.-E, Park, S.H., Lichinitser, M., Boku, N., Moehler, M.H., Hong, J., Xiong, H., Hallwachs, R., Conti, I., Taieb, J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis, maturation, and cross-presentation by dendritic cells
Moehler, Markus H, Zeidler, Maja, Wilsberg, Vanessa, Cornelis, Jan J, Woelfel, Thomas, Rommelaere, Jean, Galle, Peter R, Heike, Michael
Published in Human gene therapy (01.08.2005)
Published in Human gene therapy (01.08.2005)
Get more information
Journal Article
Quality-of-life assessment in patients with malignant ascites: Results of a multicenter phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone
Gonschior, A., Heiss, M. M., Moehler, M. H., Parsons, S. L., Gilet, H.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases—A randomized, double-blind, placebo-controlled, multicenter, multinational, phase II trial
Schimanski, C. C., Galle, P. R., Lang, H., Schoen, M., Moehler, M. H.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Trastuzumab and capecitabine in patients with HER2-expressing metastatic pancreatic cancer: A multicenter phase II study of the German AIO Pancreatic Cancer Group (AIO PK-0204)
Geissler, M., Hofheinz, R., Moehler, M. H., Bitzer, M., Boeck, S. H., Reinacher-Schick, A., Heinemann, V., Harder, J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients with resected gastric cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1)—An open-label randomized controlled phase II study
Smyth, Elizabeth Catherine, Peeters, Ellen, Knoedler, Maren Kristina, Giraut, Anne, Wagner, Anna Dorothea, Moehler, Markus H., van Grieken, Nicole C.T., Nilsson, Magnus, Mauer, Murielle E., Lordick, Florian
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2021)
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2021)
Get full text
Journal Article
Conference Proceeding
Survival analysis by pooling risk factors in AVAGAST: First-line capecitabine and cisplatin plus bevacizumab (bev) or placebo (pla) in patients (pts) with advanced gastric cancer (AGC)
Kang, Y., Ohtsu, A., Van Cutsem, E., Roman, L., Nunes, J., Li, C., Otero, D., Rivera, F., Aprile, G., Pimentel Alvarez, P. R., Moehler, M. H., Wu, J., Langer, B., Shah, M. A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Phase I/II trial of capecitabine (Cap) and oxaliplatin (Ox) in combination with bevacizumab (Bev) and imatinib (Ima) in patients with metastatic colorectal cancer (CRC): AIO KRK 0205
von Wichert, G., Hoehler, T., Schimanski, C. C., Moehler, M. H., Hofheinz, R., Kanzler, S., Hinke, A., Seufferlein, T., Siebler, J., Hochhaus, A., Arnold, D., Hallek, M., Hacker, U. T.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Lapatinib in combination with ECF/x in EGFR1 or HER2-overexpressing first-line metastatic gastric cancer (GC): A phase II randomized placebo controlled trial (EORTC 40071)
Roth, A., Moehler, M. H., Mauer, M., Schad, A., Karrasch, M., Praet, M., Lim, M. L., Das-Gupta, A., Lutz, M. P.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
An open-label, multicenter phase II trial of sunitinib for patients with chemorefractory metastatic gastric cancer
Moehler, M. H., Hartmann, J. T., Lordick, F., Al-Batran, S., Reimer, P., Trarbach, T., Ebert, M. P., Daum, S., Weihrauch, M., Galle, P. R.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
5-fluorouracil, leucovorin, and oxaliplatin with or without docetaxel in elderly (65 years or older) patients with esophagogastric cancer: FLOT65+ trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
Al-Batran, S., Ho-mann, N., Hartmann, J. T., Moehler, M. H., Pauligk, C., Probst, S., Rethwisch, V., Prasnikar, N., Stoehlmacher, J., Jaeger, E.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Toxicogenomic profiling of fluorouracil/leucovorin/oxaliplatin/docetaxel (FLOT) in advanced gastric cancer: A translational study of the German Arbeitsgemeinschaft Internistische Onkologie (AIO)
Goekkurt, E., Al-Batran, S., Kramer, M., Pauligk, C., Homann, N., Hartmann, J. T., Moehler, M. H., Hofheinz, R., Ehninger, G., Stoehlmacher, J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Docetaxel, oxaliplatin, and capecitabine (TEX regimen) in patients with advanced or metastatic gastric or gastroesophageal cancer (GC): Results from a phase II trial of the German AIO group
Arnold, D., Thuss-Patience, P. C., Stein, A., Grothe, W., Seufferlein, T., Reinacher-Schick, A., Geissler, M., Hofheinz, R., Moehler, M. H., Schmoll, H.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients with resected gastric cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): An open-label randomized controlled phase II study
Smyth, Elizabeth Catherine, Knoedler, Maren Kristina, Nilsson, Magnus, Wagner, Anna Dorothea, Moehler, Markus H., van Grieken, Nicole C.T., Giraut, Anne, Mauer, Murielle E., Lordick, Florian
Published in JOURNAL OF CLINICAL ONCOLOGY (01.02.2020)
Published in JOURNAL OF CLINICAL ONCOLOGY (01.02.2020)
Get full text
Journal Article
Conference Proceeding
Capecitabine (Cape) versus 5-fluorouracil (5-FU)–based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial
Hofheinz, R., Wenz, F. K., Post, S., Matzdorff, A., Laechelt, S., Hartmann, J. T., Müller, L., Link, H., Moehler, M. H., Kettner, E., Fritz, E., Hieber, U., Lindemann, H. W., Grunewald, M., Kremers, S., Constantin, C., Hipp, M., Gencer, D., Burkholder, I., Hochhaus, A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
A randomized, double-blind, multicenter phase II AIO trial with gemcitabine plus sorafenib versus gemcitabine plus placebo in patients with chemotherapy-naive advanced or metastatic biliary tract cancer: First safety and efficacy data
Moehler, M. H., Schimanski, C. C., Kanzler, S., Woerns, M. A., Denzer, U., Kolligs, F. T., Ebert, M. P., Distelrath, A., Geissler, M., Zeuzem, S., Lammert, F., Lohse, A. W., Dollinger, M. M., Lindig, U., Duerr, E. M., Lubomierski, N., Zimmermann, S., Kabisch, M., Schadmann-Fischer, S., Galle, P. R.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Defining two prognostic groups of metastatic gastric cancer: FLOT3 trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
Al-Batran, S., Hofheinz, R., Homann, N., Illerhaus, G., Martens, U. M., Stoehlmacher-Williams, J., Schmalenberg, H., Luley, K. B., Prasnikar, N., Egger, M., Probst, S., Hartmann, J. T., Moehler, M. H., Arnold, D., Fischbach, W., Pauligk, C., Moenig, S. P., Piso, P., Jaeger, E.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Docetaxel, oxaliplatin, and capecitabine (TEX regimen) for patients with metastatic gastric cancer: Interim results from a phase II trial by the German AIO Group
Moehler, M. H., Thuss-Patience, P., Arnold, D., Grothe, W., Stein, A., Seufferlein, T., Mantovani Loeffler, L., Geissler, M., Hofheinz, R. D., Schmoll, H.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article